Summarize the effect of the revision to the Post-IPO Balance Sheet |
|
|
|
|
|
|
|
|
|
|
|
|
As Previously |
|
|
|
|
|
|
As of February 2, 2021 |
|
Reported |
|
Adjustment |
|
As Restated |
Total assets |
|
$ |
289,785,365 |
|
$ |
— |
|
$ |
289,785,365 |
Derivative warrant liabilities |
|
|
— |
|
|
10,638,000 |
|
|
10,638,000 |
Total liabilities |
|
$ |
10,704,851 |
|
$ |
10,638,000 |
|
$ |
21,342,851 |
Class A ordinary shares subject to possible redemption |
|
|
274,080,510 |
|
|
13,419,490 |
|
|
287,500,000 |
Preferred shares |
|
|
— |
|
|
— |
|
|
— |
Class A ordinary shares |
|
|
214 |
|
|
(134) |
|
|
80 |
Class B ordinary shares |
|
|
719 |
|
|
— |
|
|
719 |
Additional paid-in capital |
|
|
5,030,402 |
|
|
(5,030,402) |
|
|
— |
Accumulated deficit |
|
|
(31,331) |
|
|
(19,026,954) |
|
|
(19,058,285) |
Total shareholders’ equity (deficit) |
|
$ |
5,000,004 |
|
$ |
(24,057,490) |
|
|
(19,057,486) |
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) |
|
$ |
289,785,365 |
|
$ |
— |
|
$ |
289,785,365 |
|